Decision Resources’ Spectrum service identifies and analyzes the key business and technology drivers of the biopharmaceutical industry and helps you position your company for tomorrow’s challenges and opportunities. This comprehensive executive advisory service is based on the best available data sources:

• Primary data: sales, prescription and pricing data for brandsand generics, and Decision Resources’ epidemiology data for diseases.

• Industry expertise: expert opinions from biopharmaceutical, diagnostic and supportive companies, thought-leading physician interviews, surveys of physicians in the trenches.

• Expert analysis: Spectrum’s industry-savvy staff analyzes data and trends and delivers critical insights and strategic recommendations.

• Comprehensive coverage: From early-stage discovery to post-marketing challenges…from biomarkers to brand strategies…from niche diseases to therapeutic area franchises, Spectrum covers the whole industry to help you fine-tune your industry expertise so that you are equipped to tap all the right opportunities.